Pay in 4 interest-free payments of $7.09 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Described as the first selective GHRP-receptor agonist. Bone Biology 1999 Bone-growth dissociated from IGF-1 (15-day rat model) Johansen and colleagues reported dose-dependent increases in longitudinal bone-growth rate in adult female rats after 15 days of ipamorelin administration, with total IGF-I and IGFBPs unchanged a dissociation of skeletal effects from the sustained IGF-1 axis in this short-duration preclinical model
Before embarking on any peptide regimen, it is crucial to consult with a healthcare professional
people tend to abandon digital programs, but they dont quit on other people
The primary risks include receptor desensitization (reduced pituitary responsiveness to GHRH and ghrelin signaling) after 24-28 weeks of continuous use, potential IGF-1 elevation beyond physiological range if not monitored, and transient side effects like joint discomfort or water retention
